1. Home
  2. IMMP vs CPZ Comparison

IMMP vs CPZ Comparison

Compare IMMP & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • CPZ
  • Stock Information
  • Founded
  • IMMP 1987
  • CPZ 2019
  • Country
  • IMMP Australia
  • CPZ United States
  • Employees
  • IMMP N/A
  • CPZ N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • CPZ Trusts Except Educational Religious and Charitable
  • Sector
  • IMMP Health Care
  • CPZ Finance
  • Exchange
  • IMMP Nasdaq
  • CPZ Nasdaq
  • Market Cap
  • IMMP 304.0M
  • CPZ 300.6M
  • IPO Year
  • IMMP N/A
  • CPZ N/A
  • Fundamental
  • Price
  • IMMP $1.83
  • CPZ $15.56
  • Analyst Decision
  • IMMP Buy
  • CPZ
  • Analyst Count
  • IMMP 2
  • CPZ 0
  • Target Price
  • IMMP $8.50
  • CPZ N/A
  • AVG Volume (30 Days)
  • IMMP 82.5K
  • CPZ 63.0K
  • Earning Date
  • IMMP 03-25-2025
  • CPZ 01-01-0001
  • Dividend Yield
  • IMMP N/A
  • CPZ 11.07%
  • EPS Growth
  • IMMP N/A
  • CPZ N/A
  • EPS
  • IMMP N/A
  • CPZ N/A
  • Revenue
  • IMMP $3,019,249.00
  • CPZ N/A
  • Revenue This Year
  • IMMP N/A
  • CPZ N/A
  • Revenue Next Year
  • IMMP $20.28
  • CPZ N/A
  • P/E Ratio
  • IMMP N/A
  • CPZ N/A
  • Revenue Growth
  • IMMP 24.11
  • CPZ N/A
  • 52 Week Low
  • IMMP $1.65
  • CPZ $13.17
  • 52 Week High
  • IMMP $3.34
  • CPZ $16.11
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 41.69
  • CPZ 53.03
  • Support Level
  • IMMP $1.65
  • CPZ $15.12
  • Resistance Level
  • IMMP $1.88
  • CPZ $15.68
  • Average True Range (ATR)
  • IMMP 0.10
  • CPZ 0.23
  • MACD
  • IMMP -0.01
  • CPZ 0.00
  • Stochastic Oscillator
  • IMMP 41.94
  • CPZ 64.06

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.

Share on Social Networks: